CWA
GDRX icon

Carolina Wealth Advisors’s GoodRx Holdings GDRX Stock Holding History

Carolina Wealth Advisors’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-10
Closed -$63 – 272
2023
Q1 		$63 Buy
+10
New +$56 ﹤0.01% 269

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
PTC
Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $781M AUM 18.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Carolina Wealth Advisors's GDRX Position: Q2 2023 in Review

Carolina Wealth Advisors sold out of GoodRx Holdings (GDRX) in Q2 2023, closing a stake of 10 shares — an estimated $63 sold.

Carolina Wealth Advisors first reported a position in GDRX in Q1 2023 and held it in 1 quarter. The position peaked at $63 in Q1 2023. 147 funds tracked by Wall St. Rank hold GDRX as of Q2 2023.

  • Carolina Wealth Advisors reported no remaining GoodRx Holdings position as of Q2 2023 after selling out during the quarter.
  • Carolina Wealth Advisors sold 10 GoodRx Holdings shares in Q2 2023, an estimated $63.
  • Carolina Wealth Advisors first reported a position in GoodRx Holdings in Q1 2023 and held it in 1 quarter.
  • Carolina Wealth Advisors's GoodRx Holdings position peaked at $63 in Q1 2023.
  • 147 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2023.

Based on Carolina Wealth Advisors's 13F filing for Q2 2023, filed 17 Jul 2023.